文献速递中毒与环境急症重症综合管理与镇静镇痛

葡萄糖-胰岛素-钾输注治疗急性磷化铝中毒:一项开放标签先导研究

Glucose-insulin-potassium infusion for the treatment of acute aluminum phosphide poisoning: an open-label pilot study.
PubMed 文献 · Clin Toxicol (Phila) · 2020-03-04
一句话结论急性磷化铝中毒患者中,GIK输注联合支持治疗较单纯支持治疗降低院内病死率(46.7% vs 73.3%,P=0.03),但住院时间延长且高血糖更常见。

该研究为印度北部一家三级医院开展的前瞻性开放标签先导研究,纳入60例13岁以上急性磷化铝中毒患者,随机分为GIK输注联合支持治疗组与单纯支持治疗组。主要终点院内病死率在GIK组为46.7%,单纯支持治疗组为73.3%(P=0.03)。GIK组住院时间更长(P<0.01)、机械通气需求减少(P<0.01),多个时间点收缩压、舒张压、平均动脉压及格拉斯哥昏迷评分改善,但脉率和代谢性酸中毒(血pH和碳酸氢盐)两组相当;GIK组高血糖显著更常见但易于处理。作者结论认为GIK输注可能改善急性磷化铝中毒患者的生存和血流动力学。

要点

  • 急性磷化铝中毒患者中,GIK输注联合支持治疗组院内病死率46.7%,单纯支持治疗组73.3%(P=0.03)。
  • GIK组机械通气需求较单纯支持治疗组减少(P<0.01),但住院时间更长(P<0.01)。
  • GIK组多个时间点收缩压、舒张压、平均动脉压及格拉斯哥昏迷评分改善,脉率与代谢性酸中毒指标两组相当。
  • GIK组高血糖显著更常见,但原文称易于处理。
  • 作者结论:GIK输注可能改善急性磷化铝中毒患者的生存和血流动力学。

适用人群与场景

  • 印度北部一家三级医院中13岁以上急性磷化铝中毒患者。

处置流程与药物剂量

  • GIK输注联合支持治疗,与单纯支持治疗对照;原文未给出GIK具体剂量、输注速度及目标血糖值。

研究设计与关键结果

  • 前瞻性开放标签先导研究,60例患者随机分配至GIK输注联合支持治疗组或单纯支持治疗组,两组基线参数可比。
  • 主要终点院内病死率:GIK组46.7% vs 单纯支持治疗组73.3%(P=0.03)。
  • 次要终点:GIK组住院时间更长(P<0.01),机械通气需求减少(P<0.01)。
  • GIK组多个时间点收缩压、舒张压、平均动脉压及格拉斯哥昏迷评分改善;脉率及代谢性酸中毒(血pH和碳酸氢盐)两组相当。
  • GIK组高血糖显著更常见,但原文称易于处理。

证据类型、等级与局限

  • 证据类型:前瞻性开放标签先导研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,GIK输注可能改善急性磷化铝中毒患者的生存和血流动力学。
  • 研究中GIK组高血糖显著更常见但易于处理,GIK组住院时间更长。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Introduction: Acute aluminum phosphide poisoning is common in low- and middle-income countries, and is associated with very high case fatality. The addition of glucose-insulin-potassium (GIK) infusion to the standard supportive care has been proposed to improve outcomes. We aimed to assess the effectiveness of GIK infusion in acute aluminum phosphide toxicity.Methods: We performed a prospective open-label pilot study in a tertiary care hospital in north India in patients over 13 years of age with acute aluminum phosphide poisoning, to determine whether the treatment with GIK infusion improved outcomes. The primary outcome was in-hospital case fatality, and the secondary outcomes were the duration of hospital stay, the requirement of mechanical ventilation, and the change in hemodynamic and metabolic parameters.Results: A total of 60 patients were randomly assigned to groups that received either GIK infusion with supportive care or supportive care alone. Baseline parameters in both groups were comparable. Treatment with GIK infusion was associated with significantly lower in-hospital case fatality compared with supportive care alone (46.7% versus 73.3%; p-value 0.03). It was associated with a longer duration of hospital stay (p-value < 0.01) and reduced requirement of mechanical ventilation (p-value < 0.01). The treatment improved blood pressure (systolic, diastolic, and mean arterial pressure) and Glasgow coma scale score at various time intervals; however, pulse rate and metabolic acidosis (blood pH and bicarbonate levels) remained comparable in both the groups. Hyperglycemia was significantly higher in the GIK group but was easily managed.Conclusion: Treatment with GIK infusion may improve survival and hemodynamics in patients with acute aluminum phosphide poisoning.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Pannu AK, Bhalla A, Gantala J, et al. Glucose-insulin-potassium infusion for the treatment of acute aluminum phosphide poisoning: an open-label pilot study. Clin Toxicol (Phila). 2020. PMID: 32129101. doi:10.1080/15563650.2020.1719131

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。